Are the point-of-care diagnostics MULTIPLATE and ROTEM valid in the setting of high concentrations of heparin and its reversal with protamine?

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 25, Issue 6, 2011, Pages 981-986

  Gertler, Ralph ^a   Wiesner, Gunther ^a   Tassani Prell, Peter ^a   Braun, Siegmund Lorenz ^a   Martin, Klaus ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

aggregometry; anticoagulants; blood; extracorporeal circulation; fibrinogen; heparin; monitoring; protamine; thromboelastometry

Indexed keywords

FIBRINOGEN; HEPARIN; PROTAMINE;

ACCURACY; ARTICLE; BLOOD SAMPLING; FEMALE; FIBRINOGEN BLOOD LEVEL; HEART SURGERY; HEPARINIZATION; HUMAN; IN VITRO STUDY; MALE; NORMAL HUMAN; POINT OF CARE TESTING; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOCYTE AGGREGATION; THROMBOELASTOGRAPHY; VALIDITY;

ADENOSINE DIPHOSPHATE; ANTICOAGULANTS; BLOOD COAGULATION TESTS; CARDIAC SURGICAL PROCEDURES; FEMALE; HEPARIN; HEPARIN ANTAGONISTS; HUMANS; MALE; PLATELET ACTIVATION; PLATELET FUNCTION TESTS; POINT-OF-CARE SYSTEMS; PROTAMINES; PROTHROMBIN TIME; REPRODUCIBILITY OF RESULTS; THROMBELASTOGRAPHY;

EID: 82255196088     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2010.11.020     Document Type: Article

References (40)

1. J.H. Essell, T.J. Martin, and J. Salinas Comparison of thromboelastography to bleeding time and standard coagulation tests in patients after cardiopulmonary bypass J Cardiothorac Vasc Anesth 7 1993 410 415
2. B.E. Miller, N.A. Guzzetta, and S.R. Tosone Rapid evaluation of coagulopathies after cardiopulmonary bypass in children using modified thromboelastography Anesth Analg 90 2000 1324 1330
3. N. Rahe-Meyer, M. Pichlmaier, and A. Haverich Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: A pilot study Br J Anaesth 102 2009 785 792
4. K.J.C. Görlinger, A. Hanke, and D. Dirkmann Perioperative coagulation management and control of platelet transfusion by point-of-care platelet function analysis Transfus Med Hemother 34 2007 396 411
5. A.T. Culliford, S.N. Gitel, and N. Starr Lack of correlation between activated clotting time and plasma heparin during cardiopulmonary bypass Ann Surg 193 1981 105 111
6. R.J. Luddington Thrombelastography/thromboelastometry Clin Lab Haematol 27 2005 81 90
7. G.N. Jackson, K.J. Ashpole, and S.M. Yentis The TEG vs the ROTEM thromboelastography/thromboelastometry systems Anaesthesia 64 2009 212 215
8. D. Bolliger, F. Szlam, and R.J. Molinaro Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: An in vitro model Br J Anaesth 102 2009 793 799
9. A.M. Mengistu, J. Mayer, and J. Boldt Whole-blood aggregometry: Are there any limits with regard to platelet counts? Acta Anaesthesiol Scand 53 2009 72 76
10. U.T. Seyfert, H. Haubelt, and A. Vogt Variables influencing multiplate(TM) whole blood impedance platelet aggregometry and turbidimetric platelet aggregation in healthy individuals Platelets 18 2007 199 206
11. A. Perkash A comparison of the quantitative action of protamine and heparin on blood coagulation Significance in clinical and laboratory usage Am J Clin Pathol 73 1980 676 681
12. P.R. Belcher, E.W. Muriithi, and E.M. Milne Heparin, platelet aggregation, neutrophils, and cardiopulmonary bypass Thromb Res 98 2000 249 256
13. R.J. Molinaro, F. Szlam, and J.H. Levy Low plasma fibrinogen levels with the Clauss method during anticoagulation with bivalirudin Anesthesiology 109 2008 160 161
14. I.J. Mackie, S. Kitchen, and S.J. Machin Guidelines on fibrinogen assays Br J Haematol 121 2003 396 404
15. G.A. DeLaria, J.J. Tyner, and C.L. Hayes Heparin-protamine mismatch A controllable factor in bleeding after open heart surgery Arch Surg 129 1994 944 950
16. F. Ni Ainle, R.J. Preston, and P.V. Jenkins Protamine sulfate down-regulates thrombin generation by inhibiting factor V activation Blood 114 2009 1658 1665
17. T. Mochizuki, P.J. Olson, and F. Szlam Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass Anesth Analg 87 1998 781 785
18. D.L. Reich, M.J. Yanakakis, and F.P. Vela-Cantos Comparison of bedside coagulation monitoring tests with standard laboratory tests in patients after cardiac surgery Anesth Analg 77 1993 673 679
19. M. Mittermayr, W. Streif, and T. Haas Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: The role of fibrinogen administration Anesth Analg 105 2007 905 917
20. D. Fries, P. Innerhofer, and C. Reif The effect of fibrinogen substitution on reversal of dilutional coagulopathy: An in vitro model Anesth Analg 102 2006 347 351
21. G.D. Williams, S.L. Bratton, and E.C. Riley Coagulation tests during cardiopulmonary bypass correlate with blood loss in children undergoing cardiac surgery J Cardiothorac Vasc Anesth 13 1999 398 404
22. M. Karlsson, L. Ternstrom, and M. Hyllner Plasma fibrinogen level, bleeding, and transfusion after on-pump coronary artery bypass grafting surgery: A prospective observational study Transfusion 48 2008 2152 2158
23. W. Prohaska, A. Zittermann, and K. Inoue Preoperative haemostasis testing does not predict requirement of blood products in cardiac surgery Eur J Med Res 13 2008 525 530
24. M. Reinhofer, M. Brauer, and U. Franke The value of rotation thromboelastometry to monitor disturbed perioperative haemostasis and bleeding risk in patients with cardiopulmonary bypass Blood Coagul Fibrinolysis 19 2008 212 219
25. D. Royston, and S. von Kier Reduced haemostatic factor transfusion using heparinase-modified thrombelastography during cardiopulmonary bypass Br J Anaesth 86 2001 575 578
26. M. Mittermayr, J. Margreiter, and C. Velik-Salchner Effects of protamine and heparin can be detected and easily differentiated by modified thrombelastography (Rotem): An in vitro study Br J Anaesth 95 2005 310 316
27. K. Zmuda, D. Neofotistos, and C.H. Ts'ao Effects of unfractionated heparin, low-molecular-weight heparin, and heparinoid on thromboelastographic assay of blood coagulation Am J Clin Pathol 113 2000 725 731
28. M.E. Carr Jr, and S.L. Carr At high heparin concentrations, protamine concentrations which reverse heparin anticoagulant effects are insufficient to reverse heparin anti-platelet effects Thromb Res 75 1994 617 630
29. V.G. Nielsen Protamine enhances fibrinolysis by decreasing clot strength: Role of tissue factor-initiated thrombin generation Ann Thorac Surg 81 2006 1720 1727
30. D.C. Mills ADP receptors on platelets Thromb Haemost 76 1996 835 856
31. K. Okano, Y. Saito, and A. Matsushima Protamine interacts with the D-domains of fibrinogen Biochim Biophys Acta 671 1981 164 167
32. T. Ammar, and C.F. Fisher The effects of heparinase 1 and protamine on platelet reactivity Anesthesiology 86 1997 1382 1386
33. R.J. Cobel-Geard, and H.I. Hassouna Interaction of protamine sulfate with thrombin Am J Hematol 14 1983 227 233
34. A.S. Kestin, C.R. Valeri, and S.F. Khuri The platelet function defect of cardiopulmonary bypass Blood 82 1993 107 117
35. S.F. Khuri, C.R. Valeri, and J. Loscalzo Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass Ann Thorac Surg 60 1995 1008 1014
36. K.E. McLaughlin, and J. Dunning In patients post cardiac surgery do high doses of protamine cause increased bleeding? Interact Cardiovasc Thorac Surg 2 2003 424 426
37. K.A. Tanaka, T. Taketomi, and F. Szlam Improved clot formation by combined administration of activated factor VII (NovoSeven) and fibrinogen (Haemocomplettan P) Anesth Analg 106 2008 732 738
38. D.R. Jobes, G.L. Aitken, and G.W. Shaffer Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion in patients undergoing primary cardiac operations J Thorac Cardiovasc Surg 110 1995 36 45
39. O. Shigeta, H. Kojima, and Y. Hiramatsu Low-dose protamine based on heparin-protamine titration method reduces platelet dysfunction after cardiopulmonary bypass J Thorac Cardiovasc Surg 118 1999 354 360
40. G.J. Despotis, J.H. Joist, and C.W. Hogue Jr The impact of heparin concentration and activated clotting time monitoring on blood conservation A prospective, randomized evaluation in patients undergoing cardiac operation J Thorac Cardiovasc Surg 110 1995 46 54